Home » Topics » Science » New compound

New compound
RSS

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

gpIIb/IIIa antagonist selected for clinical evaluation at DuPont Merck

Sep. 27, 1996

Thrombin inhibitors with improved selectivity from Servier

Sep. 27, 1996

Japanese and Korean researchers report improved antiarrhythmic agents

Sep. 27, 1996

Tyrosine kinase inhibitors from Warner-Lambert

Sep. 27, 1996

Improved dopaminergic agents from Zambon for cardiovascular disorders

Sep. 27, 1996

Orally bioavailable LTD4 antagonists from Menarini

Sep. 27, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...